Cardiometabolic multimorbidity burden and all-cause mortality after non-ST-segment elevation myocardial infarction: a multi-cohort study
Cardiometabolic multimorbidity (CMM), defined as the coexistence of at least two cardiometabolic diseases (CMDs, including myocardial infarction, diabetes, and stroke), has been established as an important risk factor for adverse cardiovascular outcomes [1-2]. However, the differential impact of varying CMM burde...